Trial Details

TERMINATED
Basic Information
Clinical ID c2168
Identifier NCT03886753
Trial Title Pharmacokinetic (PK) and Pharmacodynamics (PD) Study of Ilera Specific Products
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions ALS|Autism Spectrum Disorder|Cancer|Spasticity, Muscle|Dyskinetic Syndrome|Epilepsy|Glaucoma|Huntington Disease|Inflammatory Bowel Disease (IBD)|Multiple Sclerosis|Neuropathy|Opioid Use|Parkinson Disease|HIV/AIDS|Ptsd|Intractable Pain|Sickle Cell Disease|Terminal Illness
Interventions OTHER: Registry|OTHER: PK microsampling of blood
Participant Information
Sponsor Children's Hospital of Philadelphia
City Philadelphia
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD, ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase NULL
Time Information
Start Date 2019-05-15
Primary Completion Date 2020-06-30
Completion Date 2020-06-30